Posted in | News | Mining Business

Globex Secures Proceeds from Private Placement for Exploration Expenses

GLOBEX MINING ENTERPRISES INC. (TSX:GMX)(FRANKFURT:G1M)(OTCQX:GLBXF) informed shareholders that it has closed a private placement by issuing 70,000 "flow-through" common shares to an "accredited investor" in Ontario at a price of $1.87 per share, for a gross proceeds to Globex of $130,900.

The proceeds from the private placement will be used for exploration and hydrometallurgical test work on Globex's projects in Québec, Ontario and Nova Scotia. As a result of the closing of the private placement, there are 20,267,674 common shares of Globex issued and outstanding.

Under applicable securities legislation and the policies of the Toronto Stock Exchange, all of the foregoing common shares are subject to a hold period expiring on March 4, 2011.

This press release was written by Jack Stoch, P. Geo., President and CEO of Globex in his capacity as a Qualified Person (Q.P.) under NI 43-101.

20,267,674 shares issued and outstanding

Source:

Globex Mining Enterprises Inc.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Globex Mining Enterprises Inc.. (2019, February 18). Globex Secures Proceeds from Private Placement for Exploration Expenses. AZoMining. Retrieved on November 21, 2024 from https://www.azomining.com/News.aspx?newsID=1173.

  • MLA

    Globex Mining Enterprises Inc.. "Globex Secures Proceeds from Private Placement for Exploration Expenses". AZoMining. 21 November 2024. <https://www.azomining.com/News.aspx?newsID=1173>.

  • Chicago

    Globex Mining Enterprises Inc.. "Globex Secures Proceeds from Private Placement for Exploration Expenses". AZoMining. https://www.azomining.com/News.aspx?newsID=1173. (accessed November 21, 2024).

  • Harvard

    Globex Mining Enterprises Inc.. 2019. Globex Secures Proceeds from Private Placement for Exploration Expenses. AZoMining, viewed 21 November 2024, https://www.azomining.com/News.aspx?newsID=1173.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.